Pular para o conteúdo
Merck
Todas as fotos(1)

Key Documents

MABT1475

Anti-Cytokeratin-8 Antibody, clone 1E8

new

Sinônimo(s):

CYK8, KRT8, Keratin, type II cytoskeletal 8, Keratin-8 (K8), Type-II keratin Kb8

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Código UNSPSC:
12352203

fonte biológica

mouse

Nível de qualidade

forma do anticorpo

purified antibody

tipo de produto de anticorpo

primary antibodies

clone

1E8, monoclonal

peso molecular

calculated mol wt 53.7 kDa
observed mol wt ~54 kDa

purificado por

using protein G

reatividade de espécies

human

reatividade da espécie (prevista por homologia)

canine, monkey

embalagem

antibody small pack of 100

técnica(s)

immunocytochemistry: suitable
immunohistochemistry: suitable
inhibition assay: suitable
western blot: suitable

Isotipo

IgG2aκ

sequência de epítopo

C-terminal

nº de adesão de ID de proteína

nº de adesão UniProt

temperatura de armazenamento

-10 to -25°C

Informações sobre genes

human ... KRT8(3856)

Especificidade

Clone 1E8 is a mouse monoclonal antibody that detects human Cytokeratin-8. It targets an epitope within 12 amino acids from the C-terminal part.

Imunogênio

KLH-conjugated linear peptide corresponding to 12 amino acids from the C-terminal of human Cytokeratin-8.

Aplicação

Quality Control Testing

Evaluated by Western Blotting in HaCaT cell lysate.

Western Blotting Analysis: A 1:500 dilution of this antibody detected Cytokeratin-8 in HaCaT cell lysate.

Tested Applications

Immunohistochemistry Applications: A representative lot detected Cytokeratin-8 in Immunohistochemistry application (Sfakianos, J.P., et al. (2020). Nat Commun. 11(1):2540).

Western Blotting Analysis: A representative lot detected Cytokeratin-8 in Western Blotting application (Hembrough, T.A., et al. (1996). J Biol Chem. 271(41):25684-91).

Immunocytochemistry Analysis: A representative lot detected Cytokeratin-8 in Immunocytochemistry application (Hembrough, T.A., et al. (1996). J Biol Chem. 271(41):25684-91).

Inhibition Assay: An Anti-Cytokeratin-8, clone 1E8 Fab decreased plasminogen binding to breast cancer cell lines in Inhibition Assay (Hembrough, T.A., et al. (1996). J Biol Chem. 271(41):25684-91).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Descrição-alvo

Keratin, type II cytoskeletal 8 (UniProt: P05787; also known as Cytokeratin-8, CK-8, Keratin-8, K8, Type-II keratin Kb8) is encoded by the KRT8 (also known as CYK8) gene (Gene ID: 3856) in human. Cytokeratins belong to a diverse group of intermediate filaments that participate in differentiation and maintain the structural integrity of epithelial cells. They share a common structural organization: a central -helical rod domain flanked by head and tail domains. An important unique feature of cytokeratins is their epithelial cell-type-specific expression. CK8 is expressed in abundance in the epithelia of colon, bladder, ileum, and stomach. It is a type II, neutral to basic protein that together with cytokeratin-19 (KRT19) helps to link the contractile apparatus to dystrophin at the costameres of striated muscle. CK-8 can undergo phosphorylation on three major serine residues: Serine 23, 431, and 73. Serine 23 is highly conserved in all type II keratins. Phosphorylation at serine 73 is reported to increase during cellular stress. However, under normal conditions serine 73 remains largely dephosphorylated. It can also undergo O-glycosylation in a cell cycle-dependent manner and glycosylation increases its solubility and reduces stability by inducing proteasomal degradation. CK8 expression has been correlated with malignancy in leukoplakia and carcinomas of the head and neck and its expression has been observed in all non-small-cell lung cancers.

forma física

Purified mouse monoclonal antibody IgG2a in PBS without azide.

Reconstituição

0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Armazenamento e estabilidade

Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Outras notas

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Não está encontrando o produto certo?  

Experimente o nosso Ferramenta de seleção de produtos.

Código de classe de armazenamento

12 - Non Combustible Liquids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Certificados de análise (COA)

Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica